cjc-1295 ipamorelin vs hgh comparison anti aging Anti-Aging Peptide Therapy: Benefits in 2025 CJC-1295 vs Sermorelin: One Clear

Am J Physiol Endocrinol Metab

Two areas of emerging research deserve particular attention: Non-HIV metabolic populations: Several investigators have studied tesamorelin in adults with abdominal obesity and metabolic syndrome, with consistent signals toward VAT reduction and improvements in liver fat in patients with non-alcoholic fatty liver disease

They work through different pathways CJC-1295 is a GHRH analog that tells the pituitary to make GH, and ipamorelin is a secretagogue that triggers its release

These are not GH molecules themselves

The result is a sustained elevation of GH and IGF-1 over several days from a single dose, dosed roughly once or twice weekly

Combining them would negate the primary advantage of the peptide approach